Back |
home / stock / vtgn / vtgn message board
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: NetworkNewsBreaks VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Board Appoin | NetworkNewsWire | investorshangout | 04/27/2021 7:28:51 PM |
NetworkNewsWire: NetworkNewsBreaks VistaGen Therapeutics Inc. (NASDAQ: VTGN) Presents Data Regardin | NetworkNewsWire | investorshangout | 03/22/2021 10:02:13 PM |
NetworkNewsWire: NetworkNewsBreaks VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participatio | NetworkNewsWire | investorshangout | 03/16/2021 9:57:13 PM |
NetworkNewsWire: NetworkNewsBreaks VistaGen Therapeutics Inc.s (NASDAQ: VTGN) Pipeline Holds Potent | NetworkNewsWire | investorshangout | 03/04/2021 8:15:15 PM |
NetworkNewsWire: VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Al | NetworkNewsWire | investorshangout | 02/22/2021 7:38:26 PM |
News, Short Squeeze, Breakout and More Instantly...
VistaGen Therapeutics Inc. Company Name:
VTGN Stock Symbol:
NASDAQ Market:
VistaGen Therapeutics Inc. Website:
Vistagen Therapeutics (NASDAQ: VTGN ), a clinical-stage, neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, has received multiple new patent...
Vistagen (Nasdaq: VTGN), a clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today announced the broadening of its global in...
Vistagen (NASDAQ: VTGN) , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that it has been recognized by Mental Health America (“MHA”) for its dedication to pr...